Journal of Clinical Immunology

, Volume 28, Issue 3, pp 207–213 | Cite as

IκBα Promoter Polymorphisms in Patients with Systemic Lupus Erythematosus

  • Chia-Hui Lin
  • Shu-Chen Wang
  • Tsan-Teng Ou
  • Ruei-Nian Li
  • Wen-Chan Tsai
  • Hong-Wen Liu
  • Jeng-Hsien Yen


To investigate the associations of IκBα gene polymorphisms with the development and clinical manifestations of systemic lupus erythematosus (SLE), 110 patients with SLE and 120 unrelated healthy controls were enrolled in this study. The IκBα −881 A/G, −826 C/T, −550 A/T, −519 C/T, and −297 C/T polymorphisms were determined by the polymerase chain reaction/reaction fragment length polymorphism method. The genotype frequency of IκBα −826 C/T in the patients with SLE was significantly higher than that of the controls (p = 0.003, OR = 2.2, 95% CI = 1.3–3.9). The SLE patients also have significantly higher carriage rate of IκBα −826 T than the controls (p = 0.01, OR = 2.0, 95% CI = 1.2–3.4). We also found that the estimated haplotype frequency of IκBα −881A −826T −550A −519C −297C was significantly increased in the patients with SLE in comparison with that of the controls. This study also demonstrated that the association of IκBα −826 T with SLE was independent of HLA-DR15, which is associated with susceptibility to SLE in Taiwan. Moreover, a synergistic effect could also be found between IκBα −826 T and HLA-DR15. IκBα −826 T is associated with the development of SLE in Taiwan. The IκBα −881A −826T −550A −519C −297C haplotype is also associated with susceptibility to SLE. This study also demonstrated that IκBα -881G was associated with the occurrence of vasculitis in SLE patients. IκBα −550T might be a protective factor for the development of malar rash.


IκBα NFκB inhibitor polymorphism systemic lupus erythematosus 


  1. 1.
    Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336(15):1066–71.PubMedCrossRefGoogle Scholar
  2. 2.
    Baeuerle PA. Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle? Curr Biol 1998;8(1):R19–22.PubMedCrossRefGoogle Scholar
  3. 3.
    Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J Clin Invest 2001;107(1):7–11.PubMedCrossRefGoogle Scholar
  4. 4.
    Castro-Alcaraz S, Miskolci V, Kalasapudi B, Davidson D, Vancurova I. NF-kappa B regulation in human neutrophils by nuclear I kappa B alpha: correlation to apoptosis. J Immunol 2002;169(7):3947–53.PubMedGoogle Scholar
  5. 5.
    Dale E, Davis M, Faustman DL. A role for transcription factor NF-kappaB in autoimmunity: possible interactions of genes, sex, and the immune response. Adv Physiol Educ 2006;30(4):152–8.PubMedCrossRefGoogle Scholar
  6. 6.
    Wong HK, Kammer GM, Dennis G, Tsokos GC. Abnormal NF-kappa B activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J Immunol 1999;163(3):1682–9.PubMedGoogle Scholar
  7. 7.
    Burgos P, Metz C, Bull P, Pincheira R, Massardo L, Errazuriz C, et al. Increased expression of c-rel, from the NF-kappaB/Rel family, in T cells from patients with systemic lupus erythematosus. J Rheumatol 2000;27(1):116–27.PubMedGoogle Scholar
  8. 8.
    May MJ, Ghosh S. Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol 1997;8(2):63–73.PubMedCrossRefGoogle Scholar
  9. 9.
    Whiteside ST, Israel A. I kappa B proteins: structure, function and regulation. Semin Cancer Biol 1997;8(2):75–82.PubMedCrossRefGoogle Scholar
  10. 10.
    Lin CH OT, Wu CC, Tsai WC, Liu HW, Yen JH. IkB-alpha promoter polymorphisms in patients with rheumatoid arthritis. Intl J Immunogenet 2007;34(1):51–4CrossRefGoogle Scholar
  11. 11.
    Arenzana-Seisdedos F, Thompson J, Rodriguez MS, Bachelerie F, Thomas D, Hay RT. Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol Cell Biol 1995;15(5):2689–96.PubMedGoogle Scholar
  12. 12.
    Turpin P, Hay RT, Dargemont C. Characterization of IkappaBalpha nuclear import pathway. J Biol Chem 1999;274(10):6804–12.PubMedCrossRefGoogle Scholar
  13. 13.
    Arenzana-Seisdedos F, Turpin P, Rodriguez M, Thomas D, Hay RT, Virelizier JL, et al. Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci 1997;110(Pt 3):369–78.PubMedGoogle Scholar
  14. 14.
    Ernst MK, Dunn LL, Rice NR. The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers. Mol Cell Biol 1995;15(2):872–2.PubMedGoogle Scholar
  15. 15.
    Zheng L, Sinniah R, IHH S. Renal cell apoptosis and proliferation may be linked to nuclear factor-kappaB activation and expression of inducible nitric oxide synthase in patients with lupus nephritis. Hum Pathol 2006;37(6):637–47.PubMedCrossRefGoogle Scholar
  16. 16.
    Li WD, Dong YJ, Tu YY, Lin ZB. Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation. Int Immunopharmacol 2006;6(8):1243–50.PubMedCrossRefGoogle Scholar
  17. 17.
    Beg AA, Sha WC, Bronson RT, Baltimore D. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev 1995;9(22):2736–46.PubMedCrossRefGoogle Scholar
  18. 18.
    Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt PH, et al. IkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice. Mol Cell Biol 1996;16(5):2341–9.PubMedGoogle Scholar
  19. 19.
    Miterski B, Bohringer S, Klein W, Sindern E, Haupts M, Schimrigk S, et al. Inhibitors in the NFkappaB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations. Genes Immun 2002;3(4):211–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Mozzato-Chamay N, Corbett EL, Bailey RL, Mabey DC, Raynes J, Conway DJ. Polymorphisms in the IkappaB-alpha promoter region and risk of diseases involving inflammation and fibrosis. Genes Immun 2001;2(3):153–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Abdallah A, Sato H, Grutters JC, Veeraraghavan S, Lympany PA, Ruven HJ, et al. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun 2003;4(6):450–4.PubMedCrossRefGoogle Scholar
  22. 22.
    Romzova M, Hohenadel D, Kolostova K, Pinterova D, Fojtikova M, Ruzickova S, et al. NFkappaB and its inhibitor IkappaB in relation to type 2 diabetes and its microvascular and atherosclerotic complications. Hum Immunol 2006;67(9):706–13.PubMedCrossRefGoogle Scholar
  23. 23.
    Klein W, Tromm A, Folwaczny C, Hagedorn M, Duerig N, Epplen JT, et al. A polymorphism of the NFKBIA gene is associated with Crohn’s disease patients lacking a predisposing allele of the CARD15 gene. Int J Colorectal Dis 2004;19(2):153–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F, et al. Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood 1999;94(9):3129–4.PubMedGoogle Scholar
  25. 25.
    Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT. Mutations in the IkBa gene in Hodgkin’s disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 1999;18(20):3063–70.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Chia-Hui Lin
    • 1
  • Shu-Chen Wang
    • 2
  • Tsan-Teng Ou
    • 1
  • Ruei-Nian Li
    • 3
  • Wen-Chan Tsai
    • 1
    • 4
  • Hong-Wen Liu
    • 1
    • 4
  • Jeng-Hsien Yen
    • 1
    • 5
  1. 1.Division of Rheumatology, Department of Internal MedicineKaohsiung Medical University HospitalKaohsiung CityTaiwan
  2. 2.Department of Laboratory MedicineKaohsiung Medical University HospitalKaohsiungTaiwan
  3. 3.Faculty of Biomedical Science and Environmental BiologyKaohsiung Medical UniversityKaohsiungTaiwan
  4. 4.College of MedicineKaohsiung Medical UniversityKaohsiungTaiwan
  5. 5.Graduate Institute of Medicine, College of MedicineKaohsiung Medical UniversityKaohsiungTaiwan

Personalised recommendations